creatine has been researched along with Meningioma in 30 studies
Meningioma: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "While alanine is a relatively unique marker for meningioma, our results support the hypothesis that the combination of glutamate/creatine ratios and alanine on proton MRS is more specific and reliable for the diagnosis of meningiomas than alanine alone." | 9.12 | Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas. ( Hazany, S; Healy, JF; Hesselink, JR; Imbesi, SG, 2007) |
| "While alanine is a relatively unique marker for meningioma, our results support the hypothesis that the combination of glutamate/creatine ratios and alanine on proton MRS is more specific and reliable for the diagnosis of meningiomas than alanine alone." | 5.12 | Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas. ( Hazany, S; Healy, JF; Hesselink, JR; Imbesi, SG, 2007) |
| "The absolute concentrations of total alanine and creatine were decreased in high-grade compared with low-grade meningiomas, as was the ratio of glycine to alanine (all p < 0." | 3.76 | Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas. ( Coons, SW; Nieman, RA; Pfisterer, WK; Preul, MC; Scheck, AC; Spetzler, RF, 2010) |
| " MRS of normal brain parenchyma displays 4 main metabolites: N-acetyl aspartate (neuronal marker), creatine (cellular density marker), choline (membrane activity marker) and myoinositol (glial marker); pathological processes lead to variations of the level of these metabolites and/or the appearance of abnormal metabolites (lactate), following different patterns according to pathological process involved: glioma, meningioma, metastasis, bacterial or toxoplasmic abscess, radionecrosis." | 3.71 | [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors]. ( Confort-Gouny, S; Cozzone, PJ; Dufour, H; Galanaud, D; Le Fur, Y; Nicoli, F; Peragut, JC; Ranjeva, JP; Roche, P; Viout, P, 2002) |
| " All high-grade gliomas (n = 37) showed high choline and low or absent N-acetyl-L-aspartate and creatine along with lipid and/or lactate, whereas low-grade gliomas (n = 23) were characterized by low N-acetyl-aspartate and creatine and high choline and presence of only lactate." | 3.69 | Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. ( Chhabra, DK; Gupta, RK; Jain, VK; Pandey, R; Poptani, H; Roy, R, 1995) |
| " The NAA (N-acetylaspartate)/Cho (choline) ratio of Grade 2 astrocytoma was higher than that of Grade 4." | 3.69 | Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy. ( Bandou, K; Harada, M; Kannuki, S; Miyoshi, H; Nishitani, H; Tanouchi, M, 1995) |
| " The spectra from meningiomas, neuroblastomas, and glioblastomas displayed, in addition to similarities-including the presence of signals from leucine, isoleucine, valine, threonine, lactate, acetate, glutamate, choline-containing compounds and glycine-certain distinguishing metabolic features." | 3.69 | Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. ( Bhakoo, KK; Florian, CL; Noble, M; Preece, NE; Williams, SR, 1995) |
| "We examined 120 patients with brain tumors using a 1." | 1.31 | In vivo proton magnetic resonance spectroscopy of brain tumors. ( Fountas, KN; Gotsis, SD; Johnston, KW; Kapsalaki, EZ; Kapsalakis, JZ; Papadakis, N; Robinson, JS; Smisson , HF, 2000) |
| "Seventeen brain tumors were measured by 1H-CSI (chemical shift imaging) in a 1." | 1.30 | Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method. ( Furuya, S; Ide, M; Kizu, O; Maeda, T; Morishita, H; Naruse, S; Ueda, S, 1997) |
| "Necrosis was present histologically in four of the five meningiomas classified either as atypical or papillary." | 1.30 | Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. ( Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Nakasu, S; Shino, A, 1999) |
| "Choline was elevated in the cellular portion of both tumors but decreased in the necrotic or cystic portions." | 1.29 | Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. ( Booth, RA; Buchthal, SD; Chang, L; Cornford, M; Ernst, TM; Jenden, D; McBride, D; Miller, BL, 1995) |
| "Meningiomas were further characterized by the presence of alanine." | 1.29 | Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours. ( Blackband, SJ; Horsman, A; Lowry, M; Manton, DJ, 1995) |
| "Higher grades of brain tumors in this study were associated with higher Cho/reference and lower NAA/reference values." | 1.29 | Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. ( Arai, N; Fujiwara, S; Hara, K; Kayama, T; Kumabe, T; Ono, Y; Sato, K; Shimizu, H; Tominaga, T; Yoshimoto, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 14 (46.67) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 4 (13.33) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| De Stefano, FA | 1 |
| Morell, AA | 1 |
| Smith, G | 1 |
| Warner, T | 1 |
| Soldozy, S | 1 |
| Elarjani, T | 1 |
| Eichberg, DG | 1 |
| Luther, E | 1 |
| Komotar, RJ | 1 |
| Lin, MC | 1 |
| Li, CZ | 1 |
| Hsieh, CC | 1 |
| Hong, KT | 1 |
| Lin, BJ | 1 |
| Lin, C | 1 |
| Tsai, WC | 1 |
| Lee, CH | 1 |
| Lee, MG | 1 |
| Chung, TT | 1 |
| Tang, CT | 1 |
| Ju, DT | 1 |
| Ma, HI | 1 |
| Liu, MY | 1 |
| Chen, YH | 1 |
| Hueng, DY | 1 |
| Stadler, KL | 1 |
| Ober, CP | 1 |
| Feeney, DA | 1 |
| Jessen, CR | 1 |
| Yue, Q | 1 |
| Isobe, T | 1 |
| Shibata, Y | 1 |
| Anno, I | 1 |
| Kawamura, H | 1 |
| Yamamoto, Y | 1 |
| Takano, S | 1 |
| Matsumura, A | 1 |
| Pfisterer, WK | 1 |
| Nieman, RA | 1 |
| Scheck, AC | 1 |
| Coons, SW | 1 |
| Spetzler, RF | 1 |
| Preul, MC | 2 |
| Righi, V | 1 |
| Tugnoli, V | 1 |
| Mucci, A | 1 |
| Bacci, A | 1 |
| Bonora, S | 1 |
| Schenetti, L | 1 |
| Howe, FA | 1 |
| Barton, SJ | 1 |
| Cudlip, SA | 1 |
| Stubbs, M | 1 |
| Saunders, DE | 1 |
| Murphy, M | 1 |
| Wilkins, P | 1 |
| Opstad, KS | 1 |
| Doyle, VL | 1 |
| McLean, MA | 1 |
| Bell, BA | 1 |
| Griffiths, JR | 1 |
| Bulakbasi, N | 1 |
| Kocaoglu, M | 1 |
| Ors, F | 1 |
| Tayfun, C | 1 |
| Uçöz, T | 1 |
| Galanaud, D | 1 |
| Nicoli, F | 1 |
| Le Fur, Y | 1 |
| Roche, P | 1 |
| Confort-Gouny, S | 1 |
| Dufour, H | 1 |
| Ranjeva, JP | 1 |
| Peragut, JC | 1 |
| Viout, P | 1 |
| Cozzone, PJ | 1 |
| Bendszus, M | 2 |
| Martin-Schrader, I | 1 |
| Schlake, HP | 1 |
| Solymosi, L | 2 |
| Dydak, U | 1 |
| Meier, D | 1 |
| Lamerichs, R | 1 |
| Boesiger, P | 1 |
| Hazany, S | 1 |
| Hesselink, JR | 1 |
| Healy, JF | 1 |
| Imbesi, SG | 1 |
| Poptani, H | 1 |
| Gupta, RK | 1 |
| Roy, R | 1 |
| Pandey, R | 1 |
| Jain, VK | 1 |
| Chhabra, DK | 1 |
| Chang, L | 1 |
| McBride, D | 1 |
| Miller, BL | 1 |
| Cornford, M | 1 |
| Booth, RA | 1 |
| Buchthal, SD | 1 |
| Ernst, TM | 1 |
| Jenden, D | 1 |
| Harada, M | 1 |
| Tanouchi, M | 1 |
| Nishitani, H | 1 |
| Miyoshi, H | 1 |
| Bandou, K | 1 |
| Kannuki, S | 1 |
| Kamada, K | 1 |
| Houkin, K | 1 |
| Hida, K | 1 |
| Matsuzawa, H | 1 |
| Iwasaki, Y | 1 |
| Abe, H | 1 |
| Nakada, T | 1 |
| Manton, DJ | 1 |
| Lowry, M | 1 |
| Blackband, SJ | 1 |
| Horsman, A | 1 |
| Caramanos, Z | 1 |
| Collins, DL | 1 |
| Villemure, JG | 1 |
| Leblanc, R | 1 |
| Olivier, A | 1 |
| Pokrupa, R | 1 |
| Arnold, DL | 1 |
| Shimizu, H | 1 |
| Kumabe, T | 1 |
| Tominaga, T | 1 |
| Kayama, T | 1 |
| Hara, K | 1 |
| Ono, Y | 1 |
| Sato, K | 1 |
| Arai, N | 1 |
| Fujiwara, S | 1 |
| Yoshimoto, T | 1 |
| Florian, CL | 1 |
| Preece, NE | 1 |
| Bhakoo, KK | 1 |
| Williams, SR | 1 |
| Noble, M | 1 |
| Kinoshita, Y | 1 |
| Yokota, A | 1 |
| Furuya, S | 1 |
| Naruse, S | 1 |
| Ide, M | 1 |
| Morishita, H | 1 |
| Kizu, O | 1 |
| Ueda, S | 1 |
| Maeda, T | 1 |
| Luan, W | 1 |
| Zhang, J | 1 |
| Shino, A | 1 |
| Nakasu, S | 1 |
| Matsuda, M | 1 |
| Handa, J | 1 |
| Morikawa, S | 1 |
| Inubushi, T | 1 |
| Fountas, KN | 1 |
| Kapsalaki, EZ | 1 |
| Gotsis, SD | 1 |
| Kapsalakis, JZ | 1 |
| Smisson , HF | 1 |
| Johnston, KW | 1 |
| Robinson, JS | 1 |
| Papadakis, N | 1 |
| Warmuth-Metz, M | 1 |
| Burger, R | 1 |
| Klein, R | 1 |
| Tonn, JC | 1 |
| Czernicki, Z | 1 |
| Horsztyński, D | 1 |
| Jankowski, W | 1 |
| Grieb, P | 1 |
| Walecki, J | 1 |
| Peeling, J | 1 |
| Sutherland, G | 1 |
| Henriksen, O | 1 |
| Wieslander, S | 1 |
| Gjerris, F | 1 |
| Jensen, KM | 1 |
| Kirsch, WM | 1 |
| Schulz, Q | 1 |
| Van Buskirk, J | 1 |
| Nakane, P | 1 |
2 reviews available for creatine and Meningioma
| Article | Year |
|---|---|
Unique magnetic resonance spectroscopy profile of intracranial meningiomas compared to gliomas: a systematic review.
Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Magnetic Resonance Spectr | 2023 |
Anaerobic energy metabolism in brain tumors.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aerobiosis; Anaerobiosis; An | 1972 |
1 trial available for creatine and Meningioma
| Article | Year |
|---|---|
Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
Topics: Adult; Aged; Alanine; Biomarkers; Brain; Creatine; Female; Glutamic Acid; Glutathione; Humans; Magne | 2007 |
27 other studies available for creatine and Meningioma
| Article | Year |
|---|---|
Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS).
Topics: Adult; Aged; Aspartic Acid; Choline; Creatine; Female; Humans; Male; Meningeal Neoplasms; Meningioma | 2018 |
Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T.
Topics: Analysis of Variance; Animals; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, | 2014 |
New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma.
Topics: Adult; Aged; Biomarkers, Tumor; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; | 2008 |
Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Biomarkers, Tumor; Choline; Creatine; Diagnosis, Differenti | 2010 |
MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
Topics: 3-Hydroxybutyric Acid; Alanine; Aspartic Acid; Brain Edema; Choline; Creatine; Glutamic Acid; Glutat | 2012 |
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
Topics: Alanine; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Glioblastoma; Humans; Inosi | 2003 |
Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creat | 2003 |
[Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
Topics: Aspartic Acid; Biomarkers; Brain Abscess; Brain Neoplasms; Choline; Computer Graphics; Creatine; Dia | 2002 |
Embolisation of intracranial meningiomas without subsequent surgery.
Topics: Adolescent; Adult; Aged; Alanine; Angiography; Child; Choline; Creatine; Embolization, Therapeutic; | 2003 |
Trading spectral separation at 3T for acquisition speed in multi spin-echo spectroscopic imaging.
Topics: Aspartic Acid; Brain; Choline; Creatine; Humans; Image Enhancement; Image Processing, Computer-Assis | 2006 |
Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Child; Choline; Crea | 1995 |
Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors.
Topics: Adult; Brain Neoplasms; Choline; Creatine; Female; Glycerylphosphorylcholine; Humans; Hydrogen; Lact | 1995 |
Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
Topics: Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Ependymoma; Glioma; Humans; Magnetic | 1995 |
Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time.
Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Brain; Brain Edema; Brain Ischemia; Brain Neoplasms; Cerebr | 1994 |
Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours.
Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cerebellum; Creatine; Humans; Magnetic Resonance | 1995 |
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.
Topics: Adult; Alanine; Aspartic Acid; Astrocytoma; Biomarkers; Brain; Brain Neoplasms; Choline; Creatine; D | 1996 |
Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Femal | 1996 |
Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours.
Topics: Alanine; Amino Acids; Brain Neoplasms; Choline; Chromatography, High Pressure Liquid; Creatine; Glio | 1995 |
Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Topics: Adenoma; Adolescent; Adult; Aged; Amino Acids; Brain; Brain Neoplasms; Child; Choline; Creatine; Fem | 1997 |
Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method.
Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Evaluation Studies as Topic; Glioma; Humans; Imag | 1997 |
In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Female; Humans; Mag | 1998 |
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Biomarkers, Tumor; Brain; Cell Division; Cell Tra | 1999 |
In vivo proton magnetic resonance spectroscopy of brain tumors.
Topics: Adult; Aged; Amino Acids; Aspartic Acid; Astrocytoma; Brain; Brain Abscess; Brain Neoplasms; Choline | 2000 |
Diagnosing dural metastases: the value of 1H magnetic resonance spectroscopy.
Topics: Aged; Angiography; Aspartic Acid; Choline; Contrast Media; Creatine; Dura Mater; Female; Humans; Lac | 2001 |
Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro.
Topics: Biopsy; Brain; Brain Neoplasms; Creatine; Diagnosis, Differential; Energy Metabolism; Glioma; Humans | 2000 |
High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amino Acids; Astrocytoma; Brain; Brain Neoplasm | 1992 |
In vivo 1H-spectroscopy of human intracranial tumors at 1.5 tesla. Preliminary experience at a clinical installation.
Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Female; Humans; Lactate | 1991 |